SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (95)7/25/2001 10:04:01 PM
From: hmpa  Read Replies (1) | Respond to of 897
 
tuck,
I don't quite comprehend your logic re. Forteo's FDA review. Oral Forteo (EMIS) is preclinical, anyway, and adds probably 50 cents to EMIS valuation; besides, rejection of an injectible version of a particular drug in no way tells anything about the viability of the multi-purpose oral vehicle.